Fukushima Risk Less Than Feared

Cancers due to radiation will not increase in Japan, according to studies conducted in the wake of the 2011 nuclear disaster.

Written bySabrina Richards
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Nuclear power plant Dukovany, Czech RepublicWIKIMEDIA COMMONS, PETR ADAMEK

The radiation emitted during the Fukushima nuclear accident is unlikely to lead to increases in cancer, according to two separate studies conducted by the World Health Organization (WHO) and the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Based on estimates of radiation doses received after the accident, even cases of cancer in the nuclear plant workers highest exposed will be difficult to attribute to radiation, according to the reports on radiation exposures in the first year after the accident.

Both the WHO and UNSCEAR assessed public exposure. “If there’s a health risk, it’s with the highly exposed workers,” Wolfgang Weiss, UNSCEAR’ chair, told Nature. More than 150 nuclear plant workers received high enough exposures to slightly raise their risk of cancer, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies